Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Predictors of Residual Disease After Breast Conservation Surgery

Predictors of Residual Disease After Breast Conservation Surgery Ann Surg Oncol (2018) 25:1936–1942 https://doi.org/10.1245/s10434-018-6454-1 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y 1 2 3 Lisa J. Findlay-Shirras, HBSc, MBBS , Oussama Outbih, BSc Med, MD , Charlene N. Muzyka, MSc , 3 4,5 6,7 Katie Galloway, MSc , Pamela C. Hebbard, MD, FRCSC , and Maged Nashed, MD, PhD, FRCPC 1 2 Department of General Surgery, University of Manitoba, Winnipeg, MB, Canada; Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada; Section of General Surgery, Department of General Surgery, University of Manitoba, Winnipeg, 5 6 MB, Canada; CancerCare Manitoba, Winnipeg, MB, Canada; Radiation Oncology, Department of Radiology, University of Manitoba, Winnipeg, MB, Canada; Department of Radiation Oncology, CancerCare Manitoba, Winnipeg, MB, Canada ABSTRACT the same variables remained statistically significant on Introduction. Breast-conserving therapy is the standard of multivariable analysis. care for early-stage breast cancer. In the era of multi- Conclusions. Our results suggest that even in the absence modality therapy, the debate on the value of revision of ‘no ink on tumor’, the cancer size and grade in surgery for compromised margins continues, and high http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Predictors of Residual Disease After Breast Conservation Surgery

Download PDF
7 pages

Loading next page...
 
/lp/springer_journal/predictors-of-residual-disease-after-breast-conservation-surgery-BDyzspYg0E

References (29)

Publisher
Springer Journals
Copyright
Copyright © 2018 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
DOI
10.1245/s10434-018-6454-1
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2018) 25:1936–1942 https://doi.org/10.1245/s10434-018-6454-1 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y 1 2 3 Lisa J. Findlay-Shirras, HBSc, MBBS , Oussama Outbih, BSc Med, MD , Charlene N. Muzyka, MSc , 3 4,5 6,7 Katie Galloway, MSc , Pamela C. Hebbard, MD, FRCSC , and Maged Nashed, MD, PhD, FRCPC 1 2 Department of General Surgery, University of Manitoba, Winnipeg, MB, Canada; Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada; Section of General Surgery, Department of General Surgery, University of Manitoba, Winnipeg, 5 6 MB, Canada; CancerCare Manitoba, Winnipeg, MB, Canada; Radiation Oncology, Department of Radiology, University of Manitoba, Winnipeg, MB, Canada; Department of Radiation Oncology, CancerCare Manitoba, Winnipeg, MB, Canada ABSTRACT the same variables remained statistically significant on Introduction. Breast-conserving therapy is the standard of multivariable analysis. care for early-stage breast cancer. In the era of multi- Conclusions. Our results suggest that even in the absence modality therapy, the debate on the value of revision of ‘no ink on tumor’, the cancer size and grade in surgery for compromised margins continues, and high

Journal

Annals of Surgical Oncology – Springer Journals

Published: May 10, 2018

There are no references for this article.